Go back

Access to trials data, Euroscience president, EMA ‘orphan’ diseases…

This week in Europe in brief: Access to trials data reviewed; Euroscience names president; EMA produces list of ‘orphan’ diseases; Commission adviser dismisses fears of GM crops; Universities subsidise FP7-funded clinical trials; Amor confirmed as ERC director.

Access to trials data reviewed

The European Medicines Agency is to hold a meeting in November about access to, and transparency of, clinical trials data. The event follows the agency’s recent decision to proactively publish clinical trials data and enable access to full data sets by interested parties. It aims to assess the views and concerns of institutions and individuals on the scope and impact of the proposed changes. Expressions of interest to attend are requested by 31 October.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.